Roche | Roche's Full-Year Results 2022

Roche's Full-Year Results 2022

Agenda

Overview

Pharmaceuticals Division

Diagnostics Division

Financial Results

Questions and answers

Severin Schwan, CEO Roche Group

Thomas Schinecker, Designated CEO Roche Group as of 15 March 2023 and ad interim CEO Roche Pharmaceuticals

Matt Sause, CEO Roche Diagnostics

Alan Hippe, Chief Financial and IT Officer

Bruno Eschli, Head of Investor Relations

Please register here to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Investors

Roche has published its Full-Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 2nd February 2023.

PDF

PDF

PDF

PDF

PDF

Downloads